Terconazole Vaginal Suppositories Recalled for Temperature Storage Deviation
Cardinal Healthcare is recalling Terconazole Vaginal Suppositories (batch 1014228A) distributed nationwide because products were exposed to temperatures outside the labeled storage conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated due to a CGMP temperature exposure deviation. No illnesses, injuries, or adverse events have been reported. The hazard is theoretical, based on a manufacturing compliance issue rather than documented product failure or patient harm.
Plain-English summary
Cardinal Healthcare is recalling Terconazole Vaginal Suppositories, 80 mg (batch 1014228A), which were distributed nationwide. The product is manufactured by Cosette Pharmaceuticals, Inc., located at 111 Coolidge Street, South Plainfield, NJ 07080.
The recall was initiated because products in this batch were exposed to temperatures outside the conditions specified on the product label. This represents a deviation from Current Good Manufacturing Practice (CGMP) standards.
Consumers who possess the affected product should contact their pharmacy or healthcare provider with questions about their supply.
The recalled product
- Product
- TERCONAZOLE (TERCONAZOLE)
- Brand
- TERCONAZOLE
- Manufacturer
- CARDINAL HEALTHCARE
- Hazard
- storage-condition-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 1014228A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27